Molecular Partners AG (MOLN)
NASDAQ: MOLN · IEX Real-Time Price · USD
7.00
-0.20 (-2.78%)
At close: Jul 2, 2024, 3:58 PM
6.87
-0.13 (-1.86%)
After-hours: Jul 2, 2024, 6:45 PM EDT
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of $232.27 million as of July 2, 2024. Its market cap has increased by 8.95% in one year.
Market Cap
232.27M
Enterprise Value
43.31M
1-Year Change
8.95%
Ranking
Category
Stock Price
$7.00
Market Cap Chart
Since the IPO on June 16, 2021, Molecular Partners AG's market cap has decreased from $683.35M to $232.27M, a decrease of -66.01%. That is a compound annual growth rate of -29.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 1, 2024 | 241.60M | 75.97% |
| Dec 29, 2023 | 137.30M | -35.54% |
| Dec 30, 2022 | 213.00M | -65.47% |
| Dec 31, 2021 | 616.80M | -9.74% |
View and export this data all the way back to 2021.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sanara MedTech | 243.40M |
| Semler Scientific | 243.06M |
| Tectonic Therapeutic | 242.67M |
| AngioDynamics | 242.33M |
| Auna SA | 240.00M |
| Sutro Biopharma | 239.66M |
| Nyxoah | 239.49M |
| CorMedix | 237.97M |